James S. Shannon's Insider Trades & SAST Disclosures
James S. Shannon's most recent trade in UL Solutions Inc - Ordinary Shares - Class A was a trade of 2,787 Deferred Restricted Stock Unit done . Disclosure was reported to the exchange on May 20, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern James S. Shannon.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| UL Solutions Inc - Ordinar... | James M. Shannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2025 | 2,787 | 2,787 | - | - | Deferred Restricted Stock Unit | |
| Mannkind Corp | James S. Shannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2025 | 52,854 | 52,854 | - | - | Restricted Stock Unit | |
| UL Solutions Inc - Ordinar... | James M. Shannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2025 | 235 | 1,051 | - | - | Deferred Stock Units | |
| UL Solutions Inc - Ordinar... | James M. Shannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 12 | 49 | - | - | Dividend Equivalent Rights | |
| UL Solutions Inc - Ordinar... | James M. Shannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 261 | 816 | - | - | Deferred Stock Units | |
| UL Solutions Inc - Ordinar... | James M. Shannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2024 | 11 | 37 | - | - | Dividend Equivalent Rights | |
| UL Solutions Inc - Ordinar... | James M. Shannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2024 | 257 | 555 | - | - | Deferred Stock Units | |
| UL Solutions Inc - Ordinar... | James M. Shannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2024 | 12 | 26 | - | - | Dividend Equivalent Rights | |
| UL Solutions Inc - Ordinar... | James M. Shannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2024 | 298 | 298 | - | - | Deferred Stock Units | |
| UL Solutions Inc - Ordinar... | James M. Shannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 14 | 14 | - | - | Dividend Equivalent Rights | |
| UL Solutions Inc - Ordinar... | James M. Shannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 4,878 | 4,878 | - | - | Restricted Stock Unit | |
| Mannkind Corp | James S. Shannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 35,047 | 35,047 | - | - | Restricted Stock Unit | |
| UL Solutions Inc - Ordinar... | James M. Shannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2024 | 4,878 | 4,878 | - | - | Deferred Restricted Stock Unit | |
| UL Solutions Inc - Ordinar... | James M. Shannon | Director | Purchase of securities on an exchange or from another person at price $ 28.00 per share. | 16 Apr 2024 | 7,142 | 7,142 | - | 28 | 199,976 | Class A Common Stock |
| UL Solutions Inc - Ordinar... | James M. Shannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Apr 2024 | 4,881 | 4,881 | - | - | Restricted Stock Unit | |
| Mannkind Corp | James S. Shannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 47,393 | 47,393 | - | - | Restricted Stock Unit | |
| Horizon Therapeutics Plc | James S. Shannon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2023 | 3,913 | 23,185 (0%) | 0% | - | Ordinary Shares | |
| Horizon Therapeutics Plc | James S. Shannon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2023 | 3,913 | 0 | - | - | Restricted Stock Units | |
| Horizon Therapeutics Plc | James S. Shannon | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 111.16 per share. | 28 Apr 2023 | 1,879 | 21,306 (0%) | 0% | 111.2 | 208,870 | Ordinary Shares |
| Mannkind Corp | James S. Shannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2022 | 45,045 | 45,045 | - | - | Restricted Stock Unit | |
| Horizon Therapeutics Plc | James S. Shannon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2022 | 4,223 | 0 | - | - | Restricted Stock Units | |
| Horizon Therapeutics Plc | James S. Shannon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2022 | 4,223 | 44,568 (0%) | 0% | - | Ordinary Shares | |
| Horizon Therapeutics Plc | James S. Shannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2022 | 3,913 | 3,913 | - | - | Restricted Stock Units | |
| Horizon Therapeutics Plc | James S. Shannon | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 98.56 per share. | 28 Apr 2022 | 1,658 | 42,910 (0%) | 0% | 98.6 | 163,412 | Ordinary Shares |
| Mannkind Corp | James S. Shannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2021 | 33,860 | 33,860 | - | - | Restricted Stock Unit | |
| Mannkind Corp | James S. Shannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2021 | 11,338 | 11,338 | - | - | Restricted Stock Unit | |
| Horizon Therapeutics Plc | James S. Shannon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2021 | 11,098 | 0 | - | - | Restricted Stock Units | |
| Horizon Therapeutics Plc | James S. Shannon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2021 | 11,098 | 44,702 (0%) | 0% | - | Ordinary Shares | |
| Horizon Therapeutics Plc | James S. Shannon | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 94.62 per share. | 29 Apr 2021 | 4,357 | 40,345 (0%) | 0% | 94.6 | 412,259 | Ordinary Shares |
| Horizon Therapeutics Plc | James S. Shannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2021 | 4,223 | 4,223 | - | - | Restricted Stock Units | |
| Horizon Therapeutics Plc | James S. Shannon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.19 per share. | 01 Mar 2021 | 7,232 | 7,232 (0%) | 0% | 12.2 | 88,158 | Ordinary Shares |
| Horizon Therapeutics Plc | James S. Shannon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2021 | 7,232 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Horizon Therapeutics Plc | James S. Shannon | Director | Sale of securities on an exchange or to another person at price $ 91.30 per share. | 01 Mar 2021 | 7,232 | 0 (0%) | 0% | 91.3 | 660,261 | Ordinary Shares |
| Horizon Therapeutics Plc | James S. Shannon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2020 | 8,204 | 0 | - | - | Restricted Stock Units | |
| Horizon Therapeutics Plc | James S. Shannon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2020 | 8,204 | 36,825 (0%) | 0% | - | Ordinary Shares | |
| Horizon Therapeutics Plc | James S. Shannon | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.19 per share. | 02 Aug 2020 | 3,221 | 33,604 (0%) | 0% | 61.2 | 197,093 | Ordinary Shares |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges